MAPS Q1 2026 Earnings EPS Miss Weighs on Shares Despite Narrow Profit Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses Daktronics DAKT Q1 2026 Earnings EPS Misses Estimates Amid Supply Chain Headwinds Yet Stock Gains HXL Q1 2026 Earnings EPS Surges Past Estimates Driving Positive Market Response APPN Q1 2026 Earnings EPS Surges Past Estimates with 44 Beat Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline